Author

Birgit Zucker

Observed names: Zucker Birgit, Zucker, Birgit

Observed institutions: Boston University, Beth Israel Deaconess Medical Center, Harvard University, University of Auckland, University of Freiburg, Universität Ulm, Edith Nourse Rogers Memorial Veterans Hospital, University Medical Center Freiburg, Massachusetts General Hospital, University Medical Center Hamburg-Eppendorf, École Polytechnique Fédérale de Lausanne

OpenAlex ID: A5110171010

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

2003 · Robert J. Ferrante, James K. Kubilus, et al. · Journal of Neuroscience · 694

PDF

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 311

PDF

Cystamine increases l ‐cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation

2004 · Jonathan H. Fox, David S. Barber, et al. · Journal of Neurochemistry · 124

Sp1 Is Up-regulated in Cellular and Transgenic Models of Huntington Disease, and Its Reduction Is Neuroprotective

2006 · Zhihua Qiu, Fran Norflus, et al. · Journal of Biological Chemistry · 117

PDF

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1

2004 · Birgit Zucker, Ruth Luthi-Carter, et al. · Human Molecular Genetics · 99

Glutathione depletion in fibroblasts is the basis for apoptosis-induction by endogenous reactive oxygen species

1997 · Birgit Zucker, Jörg Hanusch, et al. · Cell Death and Differentiation · 64

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 36

Reelin Together with ApoER2 Regulates Interneuron Migration in the Olfactory Bulb

2012 · Sabine Hellwig, Iris Hack, et al. · PLoS ONE · 29

PDF

Decreased Lin7b Expression in Layer 5 Pyramidal Neurons May Contribute to Impaired Corticostriatal Connectivity in Huntington Disease

2010 · Birgit Zucker, Jibrin A. Kama, et al. · Journal of Neuropathology & Experimental Neurology · 22

Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases

2012 · Bernd Friedrich, Philipp Euler, et al. · Brain Research · 19

Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington?s disease

2004 · Birgit Zucker, DagmarE. Ludin, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 17

Neurologie compact

2022 · Andreas Hufschmidt, Sebastian Rauer, et al. · Haug Verlag in Georg Thieme Verlag KG eBooks · 9

Substantia nigra hyperechogenicity in hypokinetic Huntington’s disease patients

2015 · Johann Lambeck, Wolf-Dirk Niesen, et al. · Journal of Neurology · 8

Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice

2012 · Philipp Euler, Bernd Friedrich, et al. · Neuroscience Letters · 6

Neurologie compact

2020 · Andreas Hufschmidt, Carl Hermann Lücking, et al. · Thieme eBooks · 2

Erratum to: Substantia nigra hyperechogenicity in hypokinetic Huntington’s disease patients

2015 · Johann Lambeck, Wolf-Dirk Niesen, et al. · Journal of Neurology

PDF

Neuroprotektion

2003 · Feuerstein, Thomas J., Zucker, Birgit · FreiDok plus (Universitätsbibliothek Freiburg)

Neuroprotektion

2002 · Feuerstein, Thomas J., Zucker, Birgit · FreiDok plus (Universitätsbibliothek Freiburg)

Works count: 19

Citation count: 1,558

H-index: 11

I10-index: 11